Novo Nordisk A/S ADR buy BMO Capital Markets
Start price
12.04.24
/
50%
€119.50
Target price
12.04.25
€153.17
Performance (%)
-50.63%
End price
13.04.25
€59.00
Summary
This prediction ended on 13.04.25 with a price of €59.00. The BUY prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR performed very badly with a performance of -50.63%. BMO_Capital_Markets has a follow-up prediction for Novo Nordisk A/S ADR where he still thinks Novo Nordisk A/S ADR is a Buy. Dividends of €1.56 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 6.592% | 6.592% | -57.990% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by BMO_Capital_Markets for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $163.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€85.40
23.12.24
23.12.24
€100.93
23.12.25
23.12.25
-48.54%
15.12.25
15.12.25
Stopped prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€109.50
17.10.24
17.10.24
€144.14
17.10.25
17.10.25
-57.17%
18.10.25
18.10.25
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€115.00
08.08.24
08.08.24
€146.66
08.08.25
08.08.25
-61.04%
09.08.25
09.08.25
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€137.00
25.06.24
25.06.24
€152.14
25.06.25
25.06.25
-57.88%
26.06.25
26.06.25